Identification of five novel SLC3A1 (rBAT) gene mutations in Japanese cystinuria  by Egoshi, Ken-Ichi et al.
Kidney International, Vol. 57 (2000), pp. 25–32
Identification of five novel SLC3A1 (rBAT) gene mutations
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Identification of five novel SLC3A1 (rBAT) gene mutations cystinuria has been reported to be 1 out of 16,000 in the
in Japanese cystinuria. Japanese population [1], 1 out of 2500 in the Oriental
Background. Cystinuria is an inheritable amino aciduria and
Jewish population, and 1 out of 15,000 in the Unitedhas been classified into three subtypes: I, II, and III. One of
States population [2].the genes responsible for cystinuria has recently been identified
as SLC3A1 or rBAT, but only type I cystinuria seems to be To date only three types of classic cystinuria (I, II,
caused by genetic alterations in rBAT. To our knowledge, thus and III) have been described [3]. Type I heterozygotes
far 38 mutations in rBAT gene have been described. In this
have normal amino aciduria, whereas types II and IIIstudy, we investigated rBAT mutations in Japanese patients
heterozygotes present high or moderate hyperexcretionand compared the results with the previously reported muta-
tions in other races. of cystine and dibasic amino acids. In contrast to types
Methods. We investigated 36 Japanese cystinuria patients by I and II homozygotes, type III homozygotes show anmutational analysis of rBAT gene. To identify newly mutated
increase in plasma cystine levels after oral cystine admin-alleles, genomic DNA was analyzed by polymerase chain reac-
tion-single strand conformation polymorphism (PCR-SSCP). istration. Earlier studies suggested that these differences
When an abnormal migration was observed on SSCP, a nucleo- are attributable to allelism of the same gene [4].
tide sequence determination was performed.
In 1993, a human cDNA (D2H or rBAT) was isolatedResults. Five novel mutations were identified in five patients,
and named “SLC3A1” in the Genome Data Base; itthree with missense mutations (L346P, I445T, C673R), one
with a 1 bp deletion (1820delT), and one with a 2 bp insertion induced cystine transport in Xenopus oocytes [5]. The
(1898insTA), and we detected three previously reported poly- rBAT-encoded protein was expressed in the brush bor-
morphisms. Three of the mutations were homozygous, in whom
der membrane of both the proximal renal tubules andparents had intermarried, and two were heterozygous for each
mutations. Analysis of rBAT in family of the 1898insTA patient the small intestine [6]. The rBAT gene was mapped to
revealed that the patient had inherited the mutated allele from chromosome 2 (2p21) [7]. This chromosomal localization
his parents. correlated well with that determined by linkage analysisConclusion. Five novel mutations in the rBAT gene have
in cystinuria pedigrees [8].been identified in Japanese patients with cystinuria. A racial
difference was not apparent in the position and frequency of rBAT mutations in cystinuria patients were first re-
the mutations. ported in 1994 by Calonge et al [9]. Currently, 38 muta-
tions in the rBAT gene have been found in patients
with cystinuria from different origins [9–17]. In addition,
Cystinuria (NIM220100) is an inheritable disorder of
functional analysis demonstrated that mutations in theamino acid transport, inherited as an autosomal recessive
gene inhibit transport of cystine and dibasic amino acidstrait. This disease often leads to recurrent nephrolithia-
in Xenopus oocytes [9, 11, 15, 17]. Recently, linkagesis. Cystinuria is caused by the defective transport of
analysis suggested that only type I cystinuria was due tocystine and dibasic amino acids, arginine, lysine, and
mutations in the rBAT gene, whereas other loci shouldornithine in the brush border epithelial cells of the proxi-
be responsible for types II and III cystinuria [10, 18].mal renal tubules and intestinal tract. The incidence of
Recent studies concerning amino acid transporters sug-
gested that 4F2hc and rBAT were not transporters them-
Key words: rBAT gene mutations, type 1 cystinuria, amino acid trans-
selves and that they represented specific “guidance mole-port, nephrolithiasis, phenotype for cystinuric gene.
cules” for selected amino acid transporters [19–21].
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METHODS Ten pairs of primers were designed to cover the rBAT
coding region, shown in Figure 2, and one pair of primerPatients and DNA preparations
was labeled with T4 polynucleotide kinase, MEGALA-
Thirty-six unrelated Japanese patients, 27 males and
BEL DNA 59-End labeling kit (Takara, Shiga, Japan),
9 females, were investigated. All had an episode of deliv-
and [a-32P]ATP (3000 Ci/mmol; Amersham) [26]. PCR
ery or removal of cystine stone. Urinary excretion of
was performed on 100 ng of genomic DNA. Denatur-
cystine and dibasic amino acids was determined in 24-
ation was at 948C for 60 seconds, annealing at the temper-
hour urine samples by quantitative ion-exchange chro-
ature determined for each pair of primers, 52 to 558C
matography or reverse-phase high-pressure liquid chro-
for 30 seconds, and extension at 728C for 40 seconds,
matography. The amino acid content was corrected per
for a total number of 35 cycles. One microliter of PCR
gram of creatinine.
product was mixed with 20 mL of the aforementioned
All of the 36 patients were homozygotes according to
gel loading dye. The mixture was then heated at 808C
criteria of homozygosity by Dahlberg et al [22]. Cystine
for five minutes and chilled on ice. An aliquot of 5 mL
excretion is over 400 mg daily and/or over 250 mg/g
was loaded onto a 6% nondenaturing polyacrylamide
creatinine. In all patients, urinary hyperexcretion of di-
gel. Electrophoresis and autoradiography were carried
basic amino acids was confirmed, and the urinary excre-
out by the same method as described for RNA-SSCP.
tion of other neutral amino acids was within normal
limits. Informed consent was obtained from all patients. Nucleotide sequence determination
Four milliliters of venous blood were collected, and Nucleotide sequence determination was performed us-
DNA was isolated from blood leukocytes according to ing Thermo sequenase cycle sequencing kit (Amersham).
standard procedures. DNA was also obtained from 50 When an abnormal migration was observed on RNA-
unrelated normal individuals who served as controls. SSCP gel, the PCR products were subjected to sequencing.
On the DNA-SSCP gel, an abnormal band was carefullySearch for new mutations
excised from dried gel and placed into 100 mL of deion-
Polymerase chain reaction (PCR) and RNA-single
ized water, and the DNA was allowed to elute overnight
strand conformation polymorphism (RNA-SSCP). DNA
at room temperature. The eluted DNA was reamplified
amplification by PCR was carried out by incorporating
using the primer, and the resulting product was purified
the promoter sequence of phage T7 into one of the PCR
and sequenced. Cycle sequencing was performed using
primers [23, 24]. Ten different pairs of primers were de-
the original primers labeled using T4 polynucleotide ki-
signed based on the genomic structure of rBAT. The se-
nase and [a-32P]ATP (3000 Ci/mmol; Amersham) and
quence and location of the primers and the expected size
thermo sequenase DNA polymerase. Sequencing reac-
of the amplified products are summarized in Figure 1.
tions were electrophoresed followed by autoradiogra-
After the PCR, RNA transcription was carried out phy. The new mutations and polymorphisms found were
with 10 U of T7 RNA polymerase (Promega Biotech, checked by restriction enzyme digestion.
Madison, WI, USA) in a final volume of 10 mL containing
10 mmol/L dithiothreitol (DTT), 40 mmol/L Tris, pH
RESULTS7.5, 6 mmol/L MgCl2, 2 mmol/L spermidine, 10 mmol/L
NaCl, 5 nmol of each ribonucleoside, 10 U of RNAsin, In a sample of 36 patients with cystinuria, the whole
and 0.25 mL of [a-32P]UTP (.800 Ci/mmol; Amersham, rBAT-coding region was investigated. The five novel
Arlington Heights, IL, USA) [25]. mutations and three previously reported polymorphisms
One microliter of transcribed RNA was mixed with are shown in Table 1.
20 mL of gel loading dye, 95% formamide, 20 mmol/L
Description of five novel mutations of rBATethylenediaminetetraacetic acid, 0.05% bromophenol
blue, and 0.05% xylene cyanol. The mixture was heat In case 1, a mutation was detected in the exon 6 of
denatured at 958C for six minutes, chilled on ice for ten the rBAT gene by RNA-SSCP and DNA-SSCP. It is a
minutes, and then loaded onto a 6.5% nondenaturing T→C substitution at the nucleotide position 1037 of the
polyacrylamide gel. Electrophoresis was performed at gene. This point mutation changes a leucine codon, CTG,
40 W of constant power for eight hours. After electro- to a proline one, CCG, at position 346 (L346P). The
phoresis, the gel was transferred onto a blotting paper, patient was heterozygous for this point mutation. The
followed by autoradiography for 12 hours at 2808C. mutation destroyed an Alu I restriction site. In case 5,
Polymerase chain reaction (PCR) and DNA-single a mutation was detected in the exon 8 by DNA-SSCP.
strand conformation polymorphism (DNA-SSCP). In It is a T→C substitution at the nucleotide position 1334
of the gene. This mutation changes an isoleucine codon,addition to RNA-single strand conformation polymor-
phism (RNA-SSCP), we performed DNA-SSCP to ana- ATT, to a threonine one, ACT, at position 445 (I445T).
The patient was homozygous for this point mutation.lyze the exon areas and exon-intron boundaries that
could not be investigated by RNA-SSCP. The mutation created a Bsr I restriction site. In case 7,
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Fig. 1. Primers in the rBAT gene for RNA-
SSCP analysis.
the mutation was a T→C substitution at the nucleotide The insertion was detected by DNA-SSCP and RNA-
SSCP. This insertion also causes a frameshift, but does2017 of the rBAT gene sequence (exon 10). This muta-
tion was detected by DNA-SSCP and RNA-SSCP. The not lead to a stop codon within the open reading frame.
The patient was homozygous for this insertion.normal codon (TGC), which codes for the amino acid
cysteine at position 673, changed to an arginine codon
Description of three previously reported(CGC; C673R). The patient was heterozygous for this
polymorphisms of rBATpoint mutation. The mutation destroyed an Sph I restric-
tion site. We identified three polymorphisms that previously
have been reported [9, 10, 13].In case 12, a deletion of the nucleotide T was found
at position 1820 of the rBAT gene sequence (1820delT). A frequent polymorphism was detected in intron 7 of
the gene, seven nucleotides downstream of exon 6. ThisThe deletion was detected by DNA-SSCP and RNA-
SSCP. This deletion causes a frameshift, but does not TC substitution (1332 1 7, T→C) was detected in 9 out
of 36 (25%) affected chromosomes and in 6 of 30 (20%)lead to a stop codon within the open reading frame. The
patient appeared to be homozygous for the deletion. In unaffected Japanese. At nucleotide 114 of the rBAT
sequence, a substitution C→A (114C→A) was detected.case 29, an insertion of the nucleotide TA was observed at
position 1898 of the rBAT gene sequence (1898insTA). This substitution leads to no amino acid change. It was
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Fig. 2. Primers in the rBAT gene for DNA-
SSCP analysis.
Table 1. Five novel mutations and three previously reported polymorphisms, identified in cystinuric patients
Restriction site
Effect on
Case Mutation coding sequence Nucleotide change Created Destroyed Exon
Missense
1 L346P Leu→Pro T→C at 1037 — AluI 6
5 I445T Ile→Thr T→C at 1334 BsrI — 8
7 C673R Cys→Arg T→C at 2017 — SphI 10
Frameshift
12 1820delT Frameshift del of T at 1820 — — 10
29 1898insTA Frameshift ins of TA at 1898 — — 10
Restriction site
Polymorphism
Effect on Frequency in
coding sequence Nucleotide change Created Destroyed cystinuria
133217T/C 59 intron 7 T or C at 133217 MnlI — 9/36
G38G No aa change C or A at 114 HindIII — 8/36
M618I M or I at 618 A or G at 1854 BsmAI — 8/36
The nucleotide changes are designated according to the International Nomenclature on Human Mutations. The nucleotides are numbered taking the adenine of
the first ATG codon of rBAT cDNA sequence as number 1.
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Fig. 3. Identification of 1898insTA mutation
in a Japanese family with cystinuria. (A) A
family tree of the patient with 1898insTA. The
presence of the 1898insTA mutation is indi-
cated (*). Filled and half-filled symbols repre-
sent cystinuric patient and carriers, respec-
tively. (B) A sequence comparison of DNA
from the family members and an unaffected
control. The sequence analysis presents inser-
tion of the nucleotides TA at position 1898
of rBAT gene. The sequence analysis of the
genomic DNA from his parents revealed that
the mutation was heterozygous. They have
one normal allele and one containing an inser-
tion of TA at position 1898. He has inherited
this mutational allele from both of his parents.
detected in 8 of 36 (0.22) affected chromosomes and in In our work, three patients were found to be homozy-
7 of 30 (0.23) unaffected Japanese. An A→G substitution gous for each mutation (I445T, 1820delT, 1898insTA).
was detected at the nucleotide position 1854 (1854A→G). Parents of two of these three patients had intermarried.
This substitution leads to an amino acid change from The other two patients were heterozygous for each muta-
isoleucine to methionine. However, it was previously tion (L346P, C673R).
reported that the amino acid change (methionine→iso- Regarding the three cases of one point mutation
leucine) does not affect the function of SLC3A1 [10]. It (cases 1, 5, and 7), we performed restriction endonuclease
was detected in 8 of 36 (22%) affected chromosomes analysis on 50 unrelated normal controls. As shown in
and in 7 of 30 (23%) unaffected Japanese. Figure 4, these mutations were confirmed to be real
mutations. Restriction endonuclease analyses on cases
Identification of 1898insTA mutation in a family 12 and 29 were not performed because there was no
We collected blood and 24-hour urine samples from appropriate restriction enzyme for the diagnosis of these
parents of the patient with the 1898insTA mutation. His mutations. However, it is highly possible that these two
parents are mutually cousins. Urinary cystine and dibasic were real mutations because these mutations would pre-
amino acid excretion of parents were within normal lim- dict crucial effects on the structure and function of rBAT
its. We isolated DNA from their blood and performed protein, and analysis of the parents of case 29 showed
sequence analysis by the aforementioned technique. His that the mutation had been inherited from parents to
family tree and the results of sequence analysis are shown the case, in an autosomal recessive manner.
in Figure 3. Both of his parents were heterozygous for
this insertion, and it was logical to assume that he had
DISCUSSIONinherited the allele 1898insTA from his parents. Addi-
The standard medical treatment for cystinuria includestionally, the urinary cystine excretion level and sequence
forced hydration, urinary alkalinization, and currentlyanalyses suggested that both of his parents were type
I/N heterozygotes. certain pharmacological preparations, which solubilize
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In this study, we have found five novel rBAT mutations
associated with cystinuria, three missense mutations
(L346P, I445T, C673R), one 1 bp deletion (1820delT),
and one 2 bp insertion (1898insTA). The deletion and
the insertion can cause a frameshift, but these do not
lead to a stop codon within the open reading frame.
There was no significant difference in urinary cystine
excretion levels among the patients with these mutations.
The previously reported 38 mutations consist of 2 mis-
sense mutations in Japanese, 21 missense mutations, 2
nonsense mutations, 1 splice mutation, 2 insertion and
10 deletions (6 of these are large deletions) in other races
(Spanish, Jewish, Italian, French Canadian, American,
Persian, Arab, and Yemenite).
The mutations of the rBAT genes were compared
between Japanese and other races and these are shown
in Table 2. No apparent racial difference was found in
relation to the position or frequency of the mutations.
Five one-point mutations in the Japanese group are all
transition substitution. In contrast, 11 cases are transi-
tion, and 8 are transversion substitution in other races.
Previously, it was reported that a similar tendency had
been found in mutations of the p53 gene, a tumor sup-
pressor gene of prostate cancer [30]. Two thirds of the
p53 mutations in Japanese were found to be transver-
sions, but two thirds of p53 mutations in the United
States population were transitions. The implication of
this difference is unclear, but it might be attributed to
different etiologic factors.
In this study, three patients were homozygous and two
were heterozygous for their mutations. The parents of
three homozygous patients have intermarried, and we
were able to perform a genetic analysis of the family of
the one patient with 1898insTA. The result suggested
that both of his parents were type I/N heterozygotes, and
therefore, he could have inherited the allele 1898insTA
from his parents.
Fig. 4. Restriction digestion analysis of three cases of one point muta- Of these five novel mutations, the deletion and the
tion. The fragments were amplified using primers digested with appro- insertion should cause significant changes of the amino
priate restriction enzymes and analyzed by gel electrophoresis. (A) Alu
acid arrangement, and they were expected to have crucialI digestion of case 1 (M) and controls (C) for the L346P mutation. The
mutation destroys an Alu I site. The presence of Alu I digested products effects on the function of rBAT protein. Two of three
(53 bp, 77 bp, and 106 bp fragments) and the uncut fragment (130 bp) point mutations, L346P and C673R, were expected to
demonstrates that case 1 is heterozygous for L346P. (B) Bsr I digestion
be important for rBAT function because 346/leucine andof case 5 (M) and controls (C) for the I445T mutation. The mutation
creates a Bsr I site that cleaves the normal fragment of 317 bp into 68 673/cystine and surrounding regions were conserved in
and 249 bp fragments (the smallest fragment is not visible in the figure). both rabbit and rat rBAT genes [31, 32]. With regards
(C) Sph I digestion of case 7 (M) and controls (C) for the C673R
to I445T, 445/isoleucine is conserved in the rat rBATmutation. The mutation destroys a Sph I site. The presence of Sph I-
digested products (74 bp and 270 bp fragments) and the uncut fragment gene, but not in the rabbit rBAT gene. However, isoleu-
(344 bp) demonstrates that case 7 is heterozygous for C673R. cine, which is a nonpolar amino acid, substituted to threo-
nine, which is a polar amino acid. Thus, it is likely that
this mutation would have a significant effect on rBATcystine crystals through disulfide exchange with D-peni-
function.cillamine, a-mercaptopropionylglycine [27], or captopril
In the present study, it was almost impossible to inves-[28]. In many patients, however, these treatments may
tigate entire families by phenotypic classification becausenot completely prevent formation of new urinary stones
the parents of some patients were already dead and in[29]. Understanding the genetic basis for this disease
may facilitate development of new therapeutic strategies. other families it was difficult to obtain cooperation. Re-
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Table 2. Comparison of mutations in the rBAT gene between Japanese and other races
Exon number of mutations (point mutation and frameshift)
Position of
mutations 1 2 3 4 5 6 7 8 9 10 Sum
Japanese 0 0 0 1 0 2 0 1 0 3 7
Other races 2 2 2 2 1 2 2 6 1 9 29
Point mutation
Variety of
Frameshift Deletion Splicemutations Transition Transversion Sum
Japanese 5 0 2 0 0 7
Other races 12 11 6 6 1 36
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